Cytokines 2021 Virtual Meeting

A Hybrid Experience: In-person and Online Presentations & Sessions

As communicated previously, the ever-changing uncertainties associated with the current pandemic has placed various pressures on the organization of our forthcoming Cytokines2021 meeting. After careful reflection, the ICIS has made the hard decision to transfer the annual meeting to a FULLY VIRTUAL conference. This decision will safeguard the health and wellbeing of our delegates and alleviate the stress related to the uncertainties of traveling and in-person gatherings. 

In anticipation of this eventuality, the Local Organizing Committee and ICIS secretariat have worked hard to create a virtual event that will offer exciting opportunities to engage with friends, colleagues, and other members of the scientific community, including industrial partners and supporting academic societies. Building on the success of last year’s virtual meeting, we will ensure fruitful exchanges and presentations of original findings. 

Our industry partners have put so much effort into their interactive virtual exhibit booths and Breaking News presentations to be live streamed from their booths on Sunday before the opening session. There are many breaks in the program for participants to visit the virtual exhibits. Please note the following booths are either promoting Careers or Post-doc Opportunities in their booths and/or their Breaking News:

  • Boehringer Ingleheim 
  • GSK 
  • Janssen 
  • ICIS 
  • Korean Association of Immunologists (KAI) 
  • Pfizer 
  • Xilio 

Cytokines2021 would not be possible without the continued support of the leading companies advancing the most promising cytokine-based therapies and inhibitors, cell analysis, biomarkers, antibodies, reagents, and assay tools working on behalf of ICIS member researchers across the globe. Partnerships between the Society and Industry works to advance cytokine biology impacting all aspects of medicine, leading to new treatments in inflammation, autoimmune diseases, cancer, COVID-19, infectious disease, metabolism, microbiome health and immune-mediated conditions such as rheumatoid arthritis. We are also hugely grateful for the involvement of The Royal Society, The Learned Society of Wales, The Royal Society for Biology, The Korean Immunology Association and the Japanese Society for Cytokine and Interferon Research. Each of these academic societies have supported bespoke sessions within the program that broaden the overall content and flavor of the meeting. We are delighted to have these on board. 

We would like to wholeheartedly thank you for your confidence and support in these troubled times and remain optimistic about the success of the 2021 Virtual Meeting, with a Welsh touch of course! 

Please visit the Cytokines2021 website to view the updated program. We look forward to seeing you virtually October 17-20 (and on-demand through November 12th). 

We very much hope you enjoy the format of the meeting. 

Best regards, 

Professor Simon A Jones 
The School of Medicine 
Division of Infection & Immunity 
Cardiff University 
Cardiff, Wales, UK 

Yr Athro Simon A Jones 
Meddygaeth Prifysgol Caerdydd 
Yr Isadran Haint ac Imiwnedd 
Adeilad Tenovus 
Parc y Mynydd Bychan 
Caerdydd, Cymru, DU 

Local Organizing Committee

From Left to Right

  • Luke O’Neill, Trinity College Dublin, Ireland
  • Clare Bryant, University of Cambridge, UK
  • Clare M. Lloyd, Imperial College, UK
  • Iain McInnes, University of Glasgow, Scotland, UK
  • Simon A Jones, (Chair) Cardiff University, Wales, UK

International Scientific Advisory Committee

  • Evangelos Andreakos, Laboratory of Immunobiology, Biomedical Research Foundation, Academy of Athens, Greece
  • Yvonne Bordon, Nature Reviews Immunology, UK
  • Andrew Bowie, Trinity College Dublin, Ireland
  • Ernest Choy, Cardiff University, Wales, UK
  • Marcus Feige, TUM, Germany
  • Kate Fitzgerald, University of Massachusetts, USA
  • Trude Flow, Norwegian University of Science and Technology, Norway
  • Brian Fritz, 10x Genomics, USA
  • Sarah Gaffen, University of Pittsburgh, USA
  • Christian Holm, Aarhus University, Denmark
  • Christopher Hunter, University of Pennsylvania, USA
  • Brendan Jenkins, Hudson Institute of Medical Research, Australia
  • Gareth W. Jones, University of Bristol, UK
  • You-Me Kim, Korea Advanced Institute of Science and Technology, South Korea
  • Carolina López, Washington University in Saint Louis, USA
  • Ignacio Moraga Gonzalez, University of Dundee, Scotland, UK
  • Sandra Nicholson, Walter and Eliza Hall Institute of Medical Research, Australia
  • Anne O’Garra, Crick Institute, UK
  • Stefan Rose-John, University of Kiel, Germany
  • Ram Savan, University of Washington, USA
  • James Turkson, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, USA
  • Irina Udalova, University of Oxford, UK
  • Hiroki Yoshida, Saga University, Japan